Skip to content

Prospective cohort study on the treatment of patients with damp-heat syndrome using Shitongqing Capsule

Prospective cohort study on the treatment of patients with damp-heat syndrome using Shitongqing Capsule

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026000120
Enrollment
Unknown
Registered
2026-01-22
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic diseases, digestive and urinary system related diseases (including Western medicine diseases related to damp heat syndrome such as metabolic diseases, digestive system diseases, urinary system infections, etc.)

Interventions

Basic treatment queue:Patients should follow the previous treatment for damp heat related underlying diseases (taking traditional Chinese medicine and Western medicine other than Dehumidu Qing capsule
Shiduqing Capsule Queue:The patient follows the previous treatment for damp heat related underlying diseases (may take Western medicine, but cannot take other traditional Chinese medicine besides Dehu

Sponsors

Beijing University of Traditional Chinese Medicine Dongzhimen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Patients who meet the above traditional Chinese medicine diagnostic criteria for damp heat syndrome; 2) Age range: 18-65 years old, gender not limited; 3) Obtain the consent of the subjects and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1) Merge patients with other types of syndromes, including psychiatric patients; 2) Individuals with severe systemic diseases such as heart, lung, brain, liver, kidney, blood, endocrine, etc; 3) Individuals with abnormal liver function; 4) Pregnant and lactating women; 5) Individuals allergic to the ingredients of Shiduqing capsules; 6) Simultaneously undergoing other clinical drug trials.

Design outcomes

Primary

MeasureTime frame
Traditional Chinese Medicine Syndrome Score;

Secondary

MeasureTime frame
Blood routine+CRP;urinalysis;Routine stool test+occult blood test;Biochemistry (blood lipid indicators, albumin, liver and kidney function, etc.);

Countries

China

Contacts

Public ContactZhu Li

Beijing University of Traditional Chinese Medicine Dongzhimen Hospital

997632484@qq.com13718193505

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 7, 2026